[1] 刘 嘉,周有骏.基于微管蛋白的小分子肿瘤血管阻断剂的设计、合成及抗肿瘤活性研究[D].第二军医大学博士论文,2012.
[2] Jordan MA,Wilson L. Microtubules as a target for anticancer drugs[J]. Nat Rev Cancer,2004,4(4):253-265.
[3] Zhou J,Giannakakou P. Targeting microtubules for cancer chemotherapy[J].Curr Med Chem Anticancer Agents,2005,5(1):65-71.
[4] Liu J,Zheng CH,Zhou YJ,et al. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents[J].J Med Chem,2012,55(12):5720-5733.
[5] Yao B,Ji H,Cao Y. Synthesis and antifungal activities of novel 2-aminotetralin derivatives[J].J Med Chem,2007,50(22):5293-5300.
[6] Sun L,Tran N,Tang F. Synthesis and biological evaluations of 3-substituted indolin-2-ones:a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases[J].J Med Chem,1998,41(14):2588-2603.
[7] Corey EJ,Azimioara M,Sarshar S. X-ray crystal structure of a chiral oxazaborolidine catalyst for enantioselective carbonyl reduction[J].Tetrahedron Lett,1992,33(24):3429-3430.
[8] Hamel E. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin[J].Cell Biochem Biophys,2003,38(1):1-21.